AI-generated summary
The authors conducted a randomized, self-controlled study of 27 patients with Fitzpatrick skin types III-V and facial solar lentigines, treating each side of the face with a 532-nm picosecond laser either with or without a microlens array. Both approaches improved pigment clearance over 6 months, but postinflammatory hyperpigmentation occurred less often on the microlens array side. The authors describe the laser as safe and efficacious in this group.
- Participants
- 27
- Who or what was studied
- Patients with Fitzpatrick skin types III-V and bilateral facial solar lentigines
- Wavelengths
- 532 nm
- Limits stated in the abstract
- The abstract describes a single treatment in a small sample with follow-up only to 6 months, and it does not report a sham or untreated control.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on onlinelibrary.wiley.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Energy density (fluence)
- 0.47 J/cm2, 0.7 J/cm2
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Laser, Fluence. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.